We are pleased to welcome Mikhail (Misha) Nikiforov, Ph.D., to Duke. Nikiforov is coming to us from the Wake Forest School of Medicine and Wake Forest Comprehensive Cancer Center, where he was Professor of Cancer Biology and co-Leader of the Cancer Genetics and Metabolism Program.

Dr. Jiaoti Huang will receive a new National Institutes of Health (NIH) RO1 grant titled “Glutaminase I Isoforms as Personalized Biomarkers of Prostate Cancer”, starting January 1, 2022. The grant will support Huang lab’s long-term research goal of discovering novel biomarkers for the optimal diagnosis and treatment of patients with prostate cancer.

Ashley Rose Scholl, M.D., MSc, PGY-1, was selected to attend USCAP’s 2022 Annual Meeting with a Pathologist-in-Training Travel Award, for her project with Dr. Rami Al-Rohil, an Assistant Professor of Pathology at Duke: MALDI Imaging Mass Spectrometry Differentiates Basal Cell Carcinoma from Trichoblastoma and Trichoepithelioma.  

The Mike Slive Foundation has awarded a grant to Qianben Wang, PhD, to develop a CRISPR/Cas13d-based therapeutic nanoparticle targeting the FOXA2 transcription factor to inhibit neuroendocrine prostate cancer metastasis.

Laura Barisoni, MD, a Duke Pathology Professor, is the leading pathologist for the Nephrotic Syndrome study Network (NEPTUNE) and principal investigator of a study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It aims to study and reframe the classification of proteinuric diseases like Focal Segmental Glomerulosclerosis (FSGS) and Minimal Change Disease (MCD).

Dr. Andrea Deyrup has been giving Grand Rounds presentations across the country with her colleague, Dr. Joseph Graves, Jr. an evolutionary biology professor from North Carolina Agricultural and Technical State University.

Jiung “Peter” Nam, a third year undergraduate student in the Macias Lab, was selected to present his abstract at the 8th Annual Duke Cancer Institute (DCI) Scientific Retreat December 3rd.

Please join us in celebrating the long and highly successful career of Dr. Claudia Jones, who retired from the Duke Department of Pathology on November 30, 2021.   In honor of her many contributions to our department, medical center, and university, she has been named Associate Professor of Pathology Emerita. 

We are pleased to announce that Danielle Elliott Range, MD, has been appointed Vice Chair, Medical Director and Chief of the Division of Cytopathology.

We are pleased to announce that Sarah Bean, MD, will serve as Vice-Chair of Faculty for the Department of Pathology. In this role, she will oversee matters of faculty development, professionalism, well-being, and diversity, equity, and inclusion.